Co-Investigator - Prof Dame Lesley Fallowfield
Co-Investigator - Prof David Cella
Sponsor:
FACT-ES - Functional Assessment of Cancer Therapy - Endocrine Symptoms
Creation of an 18 item endocrine subscale (ES) to accompany a standardised breast cancer quality of life measure, the Functional Assessment of Cancer Therapy (FACT-B), to measure the side effects and putative benefits of hormonal treatments given in breast cancer. Available from FACIT.Related Publication
The impact of endocrine therapy on patients with breast cancer: a review of the literature. https://doi.org/10.1054/brst.2001.0397Related Publication
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B https://doi.org/10.1023/A:1006263818115Related Publication
Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast Cancer https://doi.org/10.1200/JCO.2005.03.3654
EMAIL: adminshore-c@sussex.ac.uk
PHONE: 01273 873019
TWITTER: https://twitter.com/SussexSHORE_C
LOCATION: MAP